M3-Brigade Acquisition V Corp. (NASDAQ:MBAV – Get Free Report) was the target of a large growth in short interest during the month of December. As of December 15th, there was short interest totaling 444,946 shares, a growth of 841.4% from the November 30th total of 47,264 shares. Based on an average trading volume of 948,174 shares, the days-to-cover ratio is currently 0.5 days. Currently, 1.2% of the shares of the company are sold short. Currently, 1.2% of the shares of the company are sold short. Based on an average trading volume of 948,174 shares, the days-to-cover ratio is currently 0.5 days.
M3-Brigade Acquisition V Stock Performance
NASDAQ:MBAV opened at $10.69 on Friday. The business has a 50 day simple moving average of $10.62 and a 200 day simple moving average of $10.82. M3-Brigade Acquisition V has a 12-month low of $10.06 and a 12-month high of $13.73.
Insider Activity
In other news, major shareholder Fitzgerald & Co. Cantor acquired 3,529,081 shares of M3-Brigade Acquisition V stock in a transaction that occurred on Wednesday, December 17th. The shares were purchased at an average cost of $10.80 per share, for a total transaction of $38,114,074.80. Following the completion of the purchase, the insider directly owned 7,779,865 shares of the company’s stock, valued at $84,022,542. This trade represents a 83.02% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Institutional Trading of M3-Brigade Acquisition V
Analysts Set New Price Targets
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research report on Monday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.
Get Our Latest Research Report on M3-Brigade Acquisition V
About M3-Brigade Acquisition V
M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.
The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.
Read More
- Five stocks we like better than M3-Brigade Acquisition V
- Washington prepares for war
- Do you know what Amazon is planning for January 1?
- Nvidia x 1,000,000
- $100 Trillion “AI Metal” Found in American Ghost Town
- Put $1,000 into this stock by Jan 1 [Not NVDA]
Receive News & Ratings for M3-Brigade Acquisition V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M3-Brigade Acquisition V and related companies with MarketBeat.com's FREE daily email newsletter.
